Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep696 | Pituitary and Neuroendocrinology | ECE2023

Clinical case of reverse hearing loss in a patient with acromegaly and pituitary macroadenoma

Perepelova Margarita , Dzeranova Larisa , Shutova Aleksandra , Lepeshkina Lyudmila , Pigarova Ekaterina , Azizyan Vilen , Akopyan Pavel , Przhiyalkovskaya Elena

Background: Acromegaly is an orphan neuroendocrine disease characterized by a variety of complications. Due to slow symptom progression acromegalic patients often are involved in growth hormone complications correction for a long time instead of search for main cause of these multiple disorders. A view on conductive hearing loss in acromegaly in literature is contradictory. The low incidence of hearing in acromegaly, compared with other complications, is presumably due to the ...

ea0035p120 | Calcium and Vitamin D metabolism | ECE2014

Calcium metabolism in a child with type 1 diabetes mellitus and familial Mediterranean fever

Bayburdyan Gayane , Arakelyan Lusine , Akopyan Sergej , Aghajanova Yelena

Introduction: Recent studies demonstrate decrease in vitamin D3 level and bone mineral density in more than 50% of type 1 diabetes (T1DM) patients. It is also suggested that vitamin D deficiency in familial mediterranean fever (FMF) patients may trigger the disease flare. These patients are at high-risk of other autoimmune diseases, as well as described combination of FMF, celiac disease, and autoimmune thyroiditis. However, there are only two case reports on combination of FM...

ea0026s10.1 | New developments in the therapy for NETs | ECE2011

New developments in the therapy for NETs: risk stratification

Pavel M

Neuroendocrine tumors (NETs) represent a rare and diverse group of tumors with predominant location in the gastro-entero-pancreatic and bronchopulmonary system. At initial diagnosis 50% of the patients present with metastatic disease whereas more than 80% develop metastases in the course of the disease with liver metastases as the most frequent ones. In consideration of the variable and sometimes indolent tumor growth behaviour, risk stratification is an important need for the...

ea0035p995 | Thyroid (non-cancer) | ECE2014

Hyperthyroidism one of the cause of pulmonary hypertension

Dokupilova Adriana , Payer Juraj , Vahala Pavel

Introduction: Hyperthyroidism is a common endocrine disorder that is associated with prominent cardiovascular manifestations. Recent studies also suggest a potential link between hyperthyroidism and pulmonary hypertension (PH). Right-sided heart failure with clinical manifestation is only occasionally seen in patients with Graves’ disease. The prevalence and pathogenic mechanisms of hyperthyroidism-related PHT remain unclear but based on literary data an autoimmune mechan...

ea0081ep730 | Pituitary and Neuroendocrinology | ECE2022

Hypogonatropic hypogonadism with craniopharyngioma in adults before and after surgery.

Klockova Irina , Astafieva Ludmila , Kalinin Pavel , Kutin Maksim , Konovalov Aleksandr

Craniopharyngiomas (CF) - a benign tumor of the embryologic origin. The surgical method of treatment is the basic.Objective: to estimate incidence of hypogonatropic hypogonadism before and after surgical treatment of CF at different topographical variations, and after the preservation of the pituitary stalk. Methods: The research involved 79 patients older than 18 years (41 women and 38 men) with a mean age - 40 [17; 69] with a ver...

ea0081ep741 | Pituitary and Neuroendocrinology | ECE2022

Growth hormone deficiency due to a rare central nervous system tumor

Gabriela Duta Simona , Pavel Sebastian , Stoica Sergiu , Fica Simona

Introduction: Short stature is a common reason for pediatric endocrine evaluation and it can have a variety of causes, including constitutional, genetic short stature, dysmorphic syndromes, chronic illnesses and also endocrine disorders. Growth hormone deficiency accounts for 8% of the cases and it can be isolated or associated with other pituitary hormones deficiencies, congenital or acquired, such as in central nervous system tumors.Case report: A 15-y...

ea0090p44 | Calcium and Bone | ECE2023

CYP24A1 mutation - a rare cause of hypercalcemia and nephrocalcinosis in adulthood

Brunerova Ludmila , Reeš Ondrej , Zoubkova Veronika , Votypka Pavel

Background: CYP24A1 gene encodes the enzyme vitamin D 24-hydroxylase, which converts active vitamin D to inactive metabolites. More than 20 currently described, usually biallelic pathogenic variants of this gene are responsible for idiopathic infantile hypercalcemia manifested typically in childhood (often in newborns) with hypercalcemia, hypercalciuria and nephrocalcinosis. However, a few patients (mostly with monoallelic heterozygous pathogenic variant) can develop mild symp...

ea0063p116 | Calcium and Bone 1 | ECE2019

Successful removal of parathyroid cancer metastasis from VI thoracic vertebra

Mokrysheva Natalia , Krupinova Julia , Gorbacheva Anna , Teplyakov Valeriy , Rumyantsev Pavel

Background: Approximately 25% of patients with parathyroid carcinoma (PC) have metastases; the most frequent sites include cervical lymph nodes (30%) and lungs (40%). Less common are liver, bones and brain. Surgical resection of local or distant metastases (if possible) provides the best control of hypercalcemia and enhances long-term survival.Case description: A 70-year old patient was admitted to hospital with a primary hyperparathyroidism (PH). He did...

ea0063p274 | Pituitary and Neuroendocrinology 1 | ECE2019

Functioning gonadotroph adenoma in a 46 years old male

Pavel Mihai Lucian , Sirbu Anca Elena , Fica Simona

Introduction: Functioning gonadotroph adenomas (FGA) are adenomas secreting and expressing biologically active gonadotropins and causing distinct clinical manifestations. The vast majority of the immunohistochemically confirmed gonadotroph adenomas are hormonally silent (presenting only with mass effects), clinically FGA’s being very rare; whereas their exact prevalence is not known.Case study: A 46 years old male patient presents to our clinic afte...

ea0063p1075 | Pituitary and Neuroendocrinology 3 | ECE2019

Emotional disorders in the clinic of the thyrotropinoma

Sidneva Yuliya , Astafyeva Ludmila , Zaitsev Oleg , Kalinin Pavel , Kadashev Boris

Thyrotropinoma (TSH-secreting pituitary adenomas, TSH-AG) are rare tumor of the pituitary (0.5–2% of all pituitary adenomas). Localization of the tumor with the appropriate neuroendocrine disorders has features in the clinic. This is due to the direct damage to the nucleus and structures of the pituitary with hypersecretion of TSH, which leads to overstimulation of the thyroid gland and the emergence of the clinical picture of ‘central’ hyperthyroidism. Differen...